//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

TIDES: Oligonucleotide and Peptide Therapeutics from Research through Commercialization

CSS

Agenda CSS

The #1 Industry Forum for CMC, Clinical and Discovery Scientists to Accelerate Product Development

May 03-06, 2015
Town and Country Resort
San Diego, CA

Scientific Advisory Board

Scientific Advisory Board

TIDES 2015 Scientific Advisory Board

Kathryn L. Ackley, Ph.D., RAC, Senior Director Cincinnati Operations, Nitto Denko Avecia Inc.

Firoz Antia, Ph.D., CMC Team Director, Pharmaceutical Operations and Technology, Biogen Idec

Mimoun Ayoub, Ph.D., Director, Global Peptides and Injectables, Corden Pharma, Switzerland

Neil H. Baine, Ph.D., President, Neil Baine Consulting, LLC and Past Executive Director, Scinovo, Preclinical Development, GlaxoSmithKline Pharmaceuticals

Doug Brooks, Ph.D., Vice President, Manufacturing Development, Ophthotech Corporation

Bob D. Brown, Ph.D., Chief Scientific Officer and Senior Vice President, Research, Dicerna Pharmaceuticals

David Brown, Ph.D., Director, Discovery and in vivo Research, Mirna Therapeutics, Inc.

Jesse Dong, Ph.D., Founder, Amphitide

Alex Fässler, Ph.D., COO Europe, Bachem AG, Switzerland

Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, Quark Pharmaceuticals, Israel

Chris Holmes, Ph.D., Former Vice President, Chemical and Pharmaceutical Development, Regado Biosciences

Peter Hoffmann, Ph.D.

Troels Koch, Ph.D., Vice President, Research and CTO, Roche Innovation Center Copenhagen, Denmark

David Litzinger, Ph.D., President, David Litzinger and Associates, LLC

John P. Mayer, Ph.D., Senior Research Scientist, Department of Chemistry, Indiana University

Muthiah (Mano) Manoharan, Ph.D., Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals, Inc.

Paul McCormac, Ph.D., Director, Biomanufacturing Sciences Group, Pfizer Global Manufacturing

Michael McGinley, Senior Product Manager- BioSeparations, Phenomenex

Bruce Morimoto, Ph.D., Executive Director Applied Translational Medicine, Drug Development Services, Celerion

Gary F. Musso, Ph.D., President, Musso and Associates LLC

Lubomir V. Nechev, Ph.D., Vice President, Process Sciences, Alnylam Pharmaceuticals, Inc.

Pamela Pavco, Ph.D., Chief Development Officer, RXi Pharmaceuticals

El Djouhar Rekaï, Head of Peptide Products Operation, Lonza, Belgium

Claus Rentel, Ph.D., Executive Director, Analytical Development/Quality Control, Isis Pharmaceuticals

Christopher A. Rhodes, Ph.D., President and CEO, Drug Delivery Experts

Christoph Rosenbohm, Ph.D., Senior Director, Research Operations, Roche Innovation Center Copenhagen, Denmark

Tomi Sawyer, Ph.D., Distinguished Scientist & Head, Peptide Drug Discovery and Innovative Technologies, Merck Research Laboratories

Trishul Shah, Associate Director, Business Development, North America, PolyPeptide Laboratories

Ved Srivastava, Ph.D. Head of Peptide Chemistry, GlaxoSmithKline

G. Susan Srivatsa, Ph.D., President, ElixinPharma

James D. Thompson, Ph.D., Head, CMC and Analytical Development, Moderna Therapeutics, Inc.

Peter Timmerman, Ph.D., Chief Scientific Officer, Pepscan Therapeutics, The Netherlands

Blake Unterreiner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc.

Thomas Vorherr, Ph.D., Director Peptide Discovery, Novartis Pharma AG, Switzerland

Paul Watt, Ph.D., Chief Scientific Officer, Phylogica Ltd., Australia

Fran Wincott, Ph.D., President, Wincott & Associates, LLC

skyline